Taylor Schreiber
Founder chez SHATTUCK LABS, INC.
Fortune : 25 M $ au 31/03/2024
Profil
Taylor H.
Schreiber is the founder.
He founded Shattuck Labs, Inc. in 2016 and currently holds the title of Chief Executive Officer & Director.
He also held the position of Director at Pelican Therapeutics, Inc. from 2011 to 2017.
Additionally, he served as the Chief Scientific Officer at Scorpius Holdings, Inc. from 2015 to 2016.
Dr. Schreiber has an undergraduate degree from Bucknell University and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SHATTUCK LABS, INC.
5,81% | 12/01/2024 | 2 757 686 ( 5,81% ) | 25 M $ | 31/03/2024 |
Postes actifs de Taylor Schreiber
| Sociétés | Poste | Début |
|---|---|---|
| SHATTUCK LABS, INC. | Founder | 01/01/2016 |
Anciens postes connus de Taylor Schreiber
| Sociétés | Poste | Fin |
|---|---|---|
Pelican Therapeutics, Inc.
 Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Director/Board Member | 01/01/2017 |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2016 |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Taylor Schreiber
| Bucknell University | Undergraduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Health Services |
